P1101: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY

Eyre, T. A., Wang, M. L., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Vandenberghe, E., Jurczak, W., Tan, X. N., Lewis, K. L., Fenske, T., Wang, Y., Coombs, C. C., Flinn, I., Lewis, D., Le Gouill, S., Gandhi, M., Chay, C., … Cheah, C. Y. (2022). P1101: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY. HemaSphere, 6, 991–992. https://doi.org/10.1097/01.hs9.0000847272.47630.ff
Authors:
Toby A. Eyre
M. L. Wang
Nirav N. Shah
Alvaro J. Alencar
James N. Gerson
Manish Patel
Bita Fakhri
Elisabeth Vandenberghe
Wojciech Jurczak
Xuan Tan
Katharine L. Lewis
Timothy S. Fenske
Y. Wang
Catherine C. Coombs
Ian W. Flinn
David John Lewis
Steven Le Gouill
M. Gandhi
C. Chay
M.Lia Palomba
Jennifer A. Woyach
John M. Pagel
Nicole Lamanna
Jeff P. Sharman
D. J. Andorsky
Jonathon B. Cohen
Minal Barve
Paolo Ghia
Ming Yin
Pier Luigi Zinzani
Chaitra S. Ujjani
Youngil Koh
Koji Izutsu
Ewa Lech‐Marańda
Jennifer Kherani
Constantine S. Tam
Suchitra Sundaram
Binoj C. Nair
Donald E. Tsai
Minna Balbas
Anthony R. Mato
Chan Y. Cheah
Affiliated Authors:
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
Viral-Related Cancers in Immunocompromised Patients (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1097/01.hs9.0000847272.47630.ff
DOI:
10.1097/01.hs9.0000847272.47630.ff
Journal:
HemaSphere
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: